Navigation Links
Two researchers known for identifying and treating 'bubble boy' disease honored by March of Dimes
Date:3/28/2014

NASHVILLE, TENNESSEE, MARCH 26, 2014 Two pediatricians whose research led to the need for early identification of and treatment of severe combined immunodeficiency (SCID) and its inclusion in newborn screening have received the March of Dimes/Col. Harland D. Sanders Lifetime Achievement Award in Genetics.

Children affected with SCID are at risk of developing life-threatening infections because they lack a normal immune system. The disorder became familiar to the public as "bubble boy disease" because an affected child, David, who was born before the wide availability of bone marrow transplantation treatment, had to live in a germ-protected environment.

Edward R.B. McCabe, MD, March of Dimes chief medical officer, presented the award to Rebecca H. Buckley, MD, professor of immunology and the J. Buren Sidbury Professor of Pediatrics at Duke University Medical Center and Jennifer M. Puck, MD, professor of pediatrics at the University of California San Francisco School of Medicine during the annual meeting of the American College of Medical Genetics today.

"Dr. Buckley and Dr. Puck together laid the groundwork for early detection of SCID. They made it possible to treat the disorder soon after birth, rather than waiting for babies with the condition to suffer from diarrhea, failure to thrive and increasingly severe bacterial, fungal and viral infections. They've given many babies a better chance for a healthy life," said Dr. McCabe.

Dr. Puck's research group was one of two teams that identified the rare X-linked recessive gene responsible for SCID-X1, and developed the newborn screening test for it. The gene Dr. Puck identified is the most common cause of SCID.

Dr. Buckley's colleagues identified other genetic causes of SCID and also showed that SCID can be effectively treated by bone marrow transplantation regardless of the molecular type. She observed a 92 percent long-term survival rate if the transplant is done in t
'/>"/>

Contact: Elizabeth Lynch
elynch@marchofdimes.coom
914-997-4286
March of Dimes Foundation
Source:Eurekalert

Page: 1 2

Related biology news :

1. Researchers at IRB discover a key regulator of colon cancer
2. Researchers reveal the dynamics behind Arctic ecosystems
3. IRCM researchers uncover a new function for an important player in the immune response
4. UGA researchers explore function of cancer-causing gene
5. Researchers present comprehensive roadmap of blood cells
6. UT Southwestern ob/gyn researchers studying genetic factors in premature births
7. Researchers issue state-of-the-state on genetic-based testing & treatment for breast cancer
8. Miscarriage clues identified in new DNA test according to researchers at Montefiore and Einstein
9. Researchers uncover allergy-cancer connection
10. Vanderbilt diabetes researchers track cells ability to regenerate
11. Researchers devise new, stretchable antenna for wearable health monitoring
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/15/2014)... The German Gauß-Allianz has admitted Johannes Gutenberg University ... the Rhineland-Palatinate science hub continues to maintain a ... computing. , "The acceptance of Johannes Gutenberg ... Gauß-Allianz is a milestone in the national and ... support. The state of Rhineland-Palatinate can be proud ...
(Date:10/15/2014)... Geneticist Fred Alt will be awarded the 44th Rosenstiel ... University for his pioneering research exploring the mechanisms of ... and cancer cells. Alt is the second alumnus to ... the Nobel Prize in 2003. , Alt is the ... Genetics at Harvard Medical School and an investigator at ...
(Date:10/14/2014)... ATHENS, Ohio (Oct. 14, 2014)—It,s been millions of years ... but a team led by Ohio University scientists is ... to model airflow through dinosaur snouts. The research has ... not only breathe but to enhance the sense of ... pretty ,nosy, animals," said Ohio University doctoral student Jason ...
Breaking Biology News(10 mins):Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 2Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 3Brandeis awards 44th Rosenstiel Award to pioneering geneticist Fred Alt 2Dinosaur breathing study shows that noses enhanced smelling and cooled brain 2Dinosaur breathing study shows that noses enhanced smelling and cooled brain 3
... daily recommended dosages of ibuprofen and acetaminophen caused a ... quadriceps muscle mass and muscle strength gained during three ... physiologists at the Human Performance Laboratory, Ball State University. ... working with Dr. Todd Trappe, reported study results at ...
... Laboratory will host the inaugural conference of the ... create a virtual center in cyberspace for plant ... "Bringing Plant and Computing Scientists Together to Solve ... 7-9, 2008, will take the first steps in ...
... As the saying goes, some people are born with ... at least one species of the animal world, according ... Alberta. A study of female red squirrels in ... as food availability and spring temperature experienced between birth ...
Cached Biology News:Ibuprofen or acetaminophen in long-term resistance training increases muscle mass/strength 2iPlant Kickoff Conference at CSHL begins tackling plant biology's grand challenges 2iPlant Kickoff Conference at CSHL begins tackling plant biology's grand challenges 3
(Date:10/25/2014)... (PRWEB) October 24, 2014 SonaCare ... focused ultrasound (HIFU) technology, announced that its Board ... as Chief Executive Officer, President and member of ... Dr. Carol will take-on expanded responsibilities within the ... as well as overseeing commercialization, manufacturing and finance. ...
(Date:10/25/2014)... 25, 2014 Berkshire Corporation, the ... to announce the release of the ValuSeal® IonX™ ... of contamination containment in critical processing applications. , ... higher cleanroom environments, ValuSeal® IonX™ is a laser ... wiper that continues Berkshire’s innovative focus on meeting ...
(Date:10/25/2014)... and NEW YORK ... Inc. (OTCQB: ACCPD), formerly Access Pharmaceuticals, Inc. (ACCP), ... areas, announced it has implemented a 1-for-50 reverse ... opening of trading on Friday, October 24, 2014. ... basis under new CUSIP number 72754H109 and temporary ...
(Date:10/25/2014)... LONDON , October 24, 2014 ... CytRx Corporation (NASDAQ: CYTR ), Vertex Pharmaceuticals ... (NASDAQ: ALXN ), Peregrine Pharmaceuticals Inc. (NASDAQ: ... Free research on these five companies can be accessed ... on Thursday, October 23, 2014, ended on a positive ...
Breaking Biology Technology:SonaCare Medical Board of Directors Appoints Dr. Mark Carol as CEO and President 2SonaCare Medical Board of Directors Appoints Dr. Mark Carol as CEO and President 3Ions Are Bygones, Berkshire Announces the Release of New Innovative Cleanroom Wipers 2PlasmaTech Biopharmaceuticals, Inc. Announces Reverse Stock Split, Ticker Change and Launches New Corporate Website 2Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 2Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 3Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 4Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 5
MAb to Vasopressin Preservative: NaN3...
... Anti-AP-2 α, clone 8G8/5 GenBank Accession ... made human AP-2alpha/gamma fusion protein corresponding to ... 278-450 of human AP-2γ Formulation: 0.1M Tris-glycine, ... before the addition of glycerol to 30% ...
Mouse monoclonal [1C6/2] to Rad17 ( Abpromise for all tested applications). entrezGeneID: 5884 SwissProtID: Q9UPF5...
MMP-2 / MMP-9 Inhibitor IV is a potent, selective, slow binding and mechanism based inhibitor of human gelatinases. • Molecular weight: 306.4 • Molecular Formula: C(15)H(14)O(3)S(2). &bul...
Biology Products: